Blackwell K - Search Results

1

Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.

Mouridsen HT, Lønning P, Beckmann MW, Blackwell K, Doughty J, Gligorov J, Llombart-Cussac A, Robidoux A, Thürlimann B, Gnant M. Mouridsen HT, et al. Among authors: blackwell k. Expert Rev Anticancer Ther. 2010 Nov;10(11):1825-36. doi: 10.1586/era.10.160. Epub 2010 Sep 30. Expert Rev Anticancer Ther. 2010. PMID: 20883112 Review.

2

The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer.

Blackwell K, Gligorov J, Jacobs I, Twelves C. Blackwell K, et al. Clin Breast Cancer. 2018 Apr;18(2):95-113. doi: 10.1016/j.clbc.2018.01.006. Epub 2018 Feb 2. Clin Breast Cancer. 2018. PMID: 29525430 Free article. Review.

3

Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease.

Herold CI, Blackwell KL. Herold CI, et al. Clin Breast Cancer. 2008 Feb;8(1):50-64. doi: 10.3816/CBC.2008.n.003. Clin Breast Cancer. 2008. PMID: 18501059 Review.

4

Are all aromatase inhibitors alike?

Blackwell KL. Blackwell KL. Breast Cancer Res Treat. 2008 Dec;112 Suppl 1:35-43. doi: 10.1007/s10549-008-0233-9. Epub 2008 Dec 20. Breast Cancer Res Treat. 2008. PMID: 19101793

5

New perspectives on zoledronic acid in breast cancer: potential augmentation of anticancer immune response.

Hamilton E, Clay TM, Blackwell KL. Hamilton E, et al. Cancer Invest. 2011 Oct;29(8):533-41. doi: 10.3109/07357907.2011.605413. Epub 2011 Aug 15. Cancer Invest. 2011. PMID: 21843051 Review.

6

The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer.

Herold CI, Blackwell KL. Herold CI, et al. Breast. 2008 Jan;17 Suppl 1:S15-24. doi: 10.1016/S0960-9776(08)70004-3. Breast. 2008. PMID: 18279763 Review.

7

Routine use of zoledronic acid in early-stage breast cancer.

Harnden K, Blackwell K. Harnden K, et al. Among authors: blackwell k. J Natl Compr Canc Netw. 2015 Apr;13(4):480-6. doi: 10.6004/jnccn.2015.0061. J Natl Compr Canc Netw. 2015. PMID: 25870382 Review.

8

Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.

Kimmick G, Edmond SN, Bosworth HB, Peppercorn J, Marcom PK, Blackwell K, Keefe FJ, Shelby RA. Kimmick G, et al. Among authors: blackwell k. Breast. 2015 Oct;24(5):630-6. doi: 10.1016/j.breast.2015.06.010. Epub 2015 Jul 16. Breast. 2015. PMID: 26189978 Free PMC article.

9

Hyperthermia for locally advanced breast cancer.

Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, Prosnitz LR, Jones EL. Zagar TM, et al. Int J Hyperthermia. 2010;26(7):618-24. doi: 10.3109/02656736.2010.501051. Int J Hyperthermia. 2010. PMID: 20849257 Free PMC article. Review.

10

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Petrakova K, Hart LL, Villanueva C, Chan A, Jakobsen E, Nusch A, Burdaeva O, Grischke EM, Alba E, Wist E, Marschner N, Favret AM, Yardley D, Bachelot T, Tseng LM, Blau S, Xuan F, Souami F, Miller M, Germa C, Hirawat S, O'Shaughnessy J. Hortobagyi GN, et al. Among authors: blackwell kl. N Engl J Med. 2016 Nov 3;375(18):1738-1748. doi: 10.1056/NEJMoa1609709. Epub 2016 Oct 7. N Engl J Med. 2016. PMID: 27717303 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page